Products

NvisionVLE Imaging
NinePoint Medical, Inc.
Gastroenterology AI
The NvisionVLE Imaging System is a high-resolution Volumetric Laser Endomicroscopy (VLE) and Optical Coherence Tomography (OCT) medical device that uses AI for real-time imaging and targeted biopsy guidance in the esophagus, pancreas, and bile duct.

See all 1 product →

About NinePoint Medical

NinePoint Medical is a medical device company specializing in advanced optical imaging for real-time, in-vivo pathology. Their flagship product, the NvisionVLE® Imaging System, utilizes Volumetric Laser Endomicroscopy (VLE), an advanced form of Optical Coherence Tomography (OCT), to provide physicians with high-resolution, cross-sectional, and volumetric digital images of tissue microstructure up to 3mm deep and 6cm long, with 7-micron resolution. This technology enables clinicians to visualize features at and below the mucosal surface that may not be apparent with conventional endoscopic imaging, aiding in the evaluation of human tissue microstructure and potentially guiding biopsy placement or treatment planning.

The NvisionVLE system, initially focused on esophageal applications, has expanded its indications to include pancreatic and biliary systems, particularly with its Low-Profile Optical Probe designed for small and tortuous anatomies. Furthermore, NinePoint Medical integrates artificial intelligence (AI) and machine learning (ML) into its platform with the Intelligent Real-time Image Segmentation (IRIS) software. IRIS assists clinicians by segmenting and visualizing esophageal image features in real-time, enhancing pattern detection and helping to identify and target regions of interest during endoscopic procedures. This convergence of advanced optical imaging and AI aims to enable earlier diagnosis of disease and more effective treatments.

Focus Areas

Gastrointestinal imaging Optical Coherence Tomography (OCT) Volumetric Laser Endomicroscopy (VLE) AI for image segmentation real-time tissue microstructure visualization early disease detection Barrett's esophagus pancreatic and biliary imaging

Business Intelligence

Key InvestorsThird Rock Ventures, Prospect Venture Partners, Corning Incorporated, Horizon Technology Finance Corporation
PartnershipsMerit Medical Systems, Inc. (exclusive worldwide distribution agreement)
AcquisitionsBankruptcy: Admin/Reorg (October 2020)
TechnologyOptical Coherence Tomography (OCT), Volumetric Laser Endomicroscopy (VLE), swept-source OCT, Intelligent Real-time Image Segmentation (IRIS) AI/Machine Learning for image feature segmentation
FDA Clearances3 cleared products (estimated)

What Physicians Need to Know

Gastrointestinal Imaging Focus
Specialization in advanced imaging techniques for the entire gastrointestinal tract.
Optical Coherence Tomography (OCT)
High-resolution, cross-sectional imaging providing detailed views of tissue microstructure.
Volumetric Laser Endomicroscopy (VLE)
3D imaging capability for comprehensive, volumetric assessment of tissue architecture.
AI for Image Segmentation
Leveraging artificial intelligence to automate and enhance the identification and analysis of critical features within imaging data.
Real-time Tissue Microstructure Visualization
Enabling immediate, live visualization of cellular and architectural changes in tissue during procedures.
Early Disease Detection
Dedicated to identifying precancerous and early-stage diseases, particularly in high-risk conditions.
Barrett's Esophagus Expertise
Specific focus and advanced tools for the surveillance and characterization of Barrett's esophagus.
Pancreatic and Biliary Imaging
Extending high-resolution imaging capabilities to complex pancreatic and biliary ductal systems.
Physician Tip

NinePoint Medical's integrated approach with OCT and VLE, augmented by AI, offers physicians unparalleled real-time, high-resolution insights into tissue microstructure. This can significantly enhance diagnostic confidence for early disease detection, particularly in conditions like Barrett's esophagus, potentially leading to earlier intervention and improved patient outcomes. The real-time visualization minimizes the need for extensive biopsies by guiding targeted sampling, making procedures more efficient and precise. For pancreatic and biliary imaging, their technology promises to provide clearer delineation of subtle abnormalities, which is crucial in these challenging anatomical areas.

NinePoint Medical's technology is designed to integrate seamlessly into existing endoscopic suites, enhancing current procedural workflows. The AI-driven image segmentation and real-time visualization capabilities suggest potential for integration with electronic health records (EHR) systems for streamlined documentation and with pathology systems for correlation of imaging findings with histological results. Future integrations could also include advanced navigation systems for even more precise targeting.

Products by NinePoint Medical

1 product in the directory

NvisionVLE Imaging
NinePoint Medical, Inc.
Gastroenterology AI
The NvisionVLE Imaging System is a high-resolution Volumetric Laser Endomicroscopy (VLE) and Optical Coherence Tomography (OCT) medical device that uses AI for real-time imaging and targeted biopsy guidance in the esophagus, pancreas, and bile duct.

Reviews & Opinions

No web reviews on file yet for NinePoint Medical. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about NinePoint Medical.

Loading videos...

Videos load interactively. If none appear, search YouTube for NinePoint Medical →

View all on YouTube

Press & Coverage

Imaging Technology News
FDA Clears NvisionVLE Imaging System for Pancreatic and Biliary Applications
NinePoint Medical received FDA clearance for its NvisionVLE Imaging System for use in the pancreas and bile duct, expanding its existing esophageal applications. This system provides real-time, high-resolution volumetric images to help gastroenterologists evaluate tissue.
2019-08
Fierce Biotech
FDA clears NinePoint's OCT imaging catheter for use in bile ducts, pancreas | Fierce Biotech
The FDA cleared NinePoint Medical's catheter-based imaging device for real-time viewing inside the pancreas and bile duct, building on its previous esophageal uses. The NvisionVLE system provides high-resolution, volumetric scans to help evaluate blockages and guide biopsies.
2019-08
NS Medical Devices
FDA approves NinePoint's NvisionVLE imaging system for pancreatic - NS Medical Devices
NinePoint Medical secured FDA approval for its NvisionVLE imaging system for pancreatic and biliary applications, extending its use beyond esophageal imaging. This approval allows for the system's use in the pancreas and bile duct, providing two-dimensional, cross-sectional, real-time depth visualization.
2019-08
NAI 500
NinePoint Medical Announces FDA Clearance of an Artificial Intelligence Software Upgrade for the NvisionVLEu00ae Imaging System | NAI 500
NinePoint Medical received FDA clearance for its Intelligent Real-time Image Segmentation (IRIS) software upgrade for the NvisionVLE Imaging System. This AI-based platform is designed to segment and visualize esophageal image features in real-time, assisting clinicians in identifying and targeting regions of interest.
2018-11
BioSpace
NinePoint Medical Release: New Clinical Data Using the NvisionVLE Imaging System to Be Presented at the World Congress of Gastroenterology At ACG 2017 and UEGW 2017 - BioSpace
NinePoint Medical announced that new clinical data for its NvisionVLE Imaging System with Real-time Targetingu2122 would be presented at the World Congress of Gastroenterology. The system offers a unique perspective of esophageal disease by imaging within the esophageal wall.
2017-10
MedCity News
NinePoint Medical adds roughly $31M to back its imaging technology - MedCity News
NinePoint Medical raised approximately $30.7 million to support its medical imaging technology, the NvisionVLE system, which allows for precise detection of areas needing biopsy in the esophagus. This funding follows previous rounds and a $15 million loan.
2015-12
Fierce Biotech
Third Rock's NinePoint Medical gets $15M in debt for novel imaging | Fierce Biotech
NinePoint Medical secured $15 million in debt financing to support the marketing of its NvisionVLE Imaging System for endoscopic volumetric imaging of the esophagus. The company was founded in 2009 by Third Rock Ventures and Prospect Venture Partners.
2015-02
MassDevice
NinePoint Medical Raises $34 million in Series B funding
Optical imaging company NinePoint Medical raised $34 million in a Series B funding round, led by Corning Incorporated, to support the ongoing commercial launch of its NvisionVLE Imaging System. The system provides high-resolution, cross-sectional images of organs and tissues.
2014-03

Frequently Asked Questions

NinePoint Medical's flagship product is the NvisionVLEu00ae Imaging System, which employs Volumetric Laser Endomicroscopy (VLE) technology. This system uses advanced Optical Coherence Tomography (OCT) to provide high-resolution, cross-sectional, real-time depth visualization of human tissue microstructure.
The NvisionVLE system enables clinicians to evaluate large segments of esophageal tissue microstructure, identifying luminal and subsurface abnormalities that might be missed by conventional endoscopy. Studies have shown that including VLE imaging can significantly increase neoplasia detection in Barrett's Esophagus patients, potentially leading to improved biopsy targeting and more effective treatment decisions.
Yes, NinePoint Medical's NvisionVLE Imaging System, along with its Low-Profile Optical Probe, received FDA clearance for use in the pancreas and bile duct. This allows gastroenterologists to thoroughly evaluate tissue for regions of interest beneath the surface in these small and tortuous anatomies, which may not be visible with other imaging technologies.
NinePoint Medical introduced the Intelligent Real-time Image Segmentation (IRIS) product, an FDA-cleared AI-based platform for image feature segmentation in gastroenterology applications. IRIS uses machine learning algorithms to segment and visualize esophageal image features in real-time, assisting clinicians in identifying and targeting regions of interest during endoscopic procedures.
The NvisionVLE Imaging System has received multiple FDA 510(k) clearances for evaluating human tissue microstructure, including esophageal, pancreatic, and biliary applications. NinePoint Medical has an exclusive worldwide distribution partnership with Merit Medical Systems, Inc.
The NvisionVLE system, utilizing advanced OCT, captures images up to 3mm beneath the mucosa at a high resolution of 7 microns. It provides real-time, two-dimensional, cross-sectional views, allowing for a comprehensive evaluation of 100% of the tissue in a 6cm scan.
NinePoint Medical is a privately-held medical device company that has secured significant funding rounds, including Series A and B. They maintain a strategic collaboration with Merit Medical Systems, Inc., which acts as their exclusive worldwide distributor, indicating ongoing market presence and support for their NvisionVLE Imaging System.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.